Compare Stocks: ZEN, PHAR, SAVE, and AXL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXL InPlay Oil		C$0.00	C$13.38 ▼ C$20.27	N/A	N/A	2.39 million shs	1.80 million shs
PHAR Pharming Group	$10.46 +0.2%	$11.44	$9.62 ▼ $21.34	$740.34M	0.01	29,831 shs	128,536 shs
ZEN Zentek	C$0.74 -1.3%	C$0.80	C$0.52 ▼ C$1.50	C$93.70M	0.334737	145,552 shs	29,320 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PHAR Pharming Group	0.00%	-0.85%	-11.21%	-22.52%	-29.47%
ZEN Zentek	0.00%	-2.63%	-3.90%	+4.23%	-37.82%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXL InPlay Oil		C$0.00	C$13.38 ▼ C$20.27	N/A	N/A	2.39 million shs	1.80 million shs
PHAR Pharming Group	$10.46 +0.2%	$11.44	$9.62 ▼ $21.34	$740.34M	0.01	29,831 shs	128,536 shs
ZEN Zentek	C$0.74 -1.3%	C$0.80	C$0.52 ▼ C$1.50	C$93.70M	0.334737	145,552 shs	29,320 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PHAR Pharming Group	0.00%	-0.85%	-11.21%	-22.52%	-29.47%
ZEN Zentek	0.00%	-2.63%	-3.90%	+4.23%	-37.82%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AXL InPlay Oil	0.00	N/A	N/A	N/A
PHAR Pharming Group	2.20	Hold	$38.67	269.66% Upside
ZEN Zentek	4.00	Strong Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest ZEN, PHAR, SAVE, and AXL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/23/2026	PHAR Pharming Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$38.00
9/22/2026	PHAR Pharming Group	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$37.00
9/14/2026	PHAR Pharming Group	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$37.00
9/14/2026	ZEN Zentek	Atrium Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
8/7/2026	PHAR Pharming Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
8/3/2026	PHAR Pharming Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$37.00 ➝ $38.00
7/31/2026	PHAR Pharming Group	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/30/2026	PHAR Pharming Group	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 9/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AXL InPlay Oil	N/A	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	$376.13M	1.97	$0.20 per share	52.16	$3.95 per share	2.65
ZEN Zentek	C$108.25K	865.57	C$0.05 per share	13.85	C$0.22 per share	3.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AXL InPlay Oil	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	$2.85M	$0.12	87.17	41.84	N/A	2.51%	3.40%	1.90%	11/5/2026 (Estimated)
ZEN Zentek	-C$10.75M	-C$0.10	N/A	N/A	N/A	-9,652.83%	-70.73%	-27.09%	N/A

Latest ZEN, PHAR, SAVE, and AXL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/30/2026	Q2 2026	PHAR Pharming Group	$0.0630	$0.02	-$0.0430	$0.02	$99.52 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AXL InPlay Oil	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	N/A	N/A	N/A	N/A	N/A
ZEN Zentek	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AXL InPlay Oil	N/A	N/A	N/A
PHAR Pharming Group	0.34	3.01	2.31
ZEN Zentek	7.62	4.65	7.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AXL InPlay Oil	N/A
PHAR Pharming Group	0.03%
ZEN Zentek	0.05%

Insider Ownership

Company	Insider Ownership
AXL InPlay Oil	N/A
PHAR Pharming Group	2.07%
ZEN Zentek	6.01%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AXL InPlay Oil	19,000	N/A	N/A	Not Optionable
PHAR Pharming Group	407	70.78 million	69.31 million	Not Optionable
ZEN Zentek	24	126.62 million	N/A	Not Optionable

ZEN, PHAR, SAVE, and AXL Headlines

Recent News About These Companies

Zentek Files Technical Report Confirming US$3.85 Billion NPV for Albany Graphite Project

September 25 at 10:04 AM | finance.yahoo.com

Zentek Files Technical Report for the Albany Graphite PEA: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to Ultra-High-Purity ...

September 24 at 1:55 PM | finance.yahoo.com

Zentek (CVE:ZEN) Stock Price Passes Below Two Hundred Day Moving Average - What's Next?

September 24 at 2:41 AM | americanbankingnews.com

Q2 Earnings Estimate for Zentek Issued By Atrium Research

September 18, 2026 | americanbankingnews.com

Zentek (CVE:ZEN) Upgraded at Atrium Research

September 17, 2026 | americanbankingnews.com

Zentek Secures Pre-Qualification in Canada’s Defence Drone Marketplace

September 16, 2026 | tipranks.com

Zentek Ltd. Begins Trading on OTCQX Best Market

September 2, 2026 | financialpost.comF

Zentek Shifts U.S. Trading to OTCQX as Nasdaq Listing Suspended

September 1, 2026 | tipranks.com

Zentek Shares to Shift From Nasdaq to OTC Markets After Delisting Notice

August 28, 2026 | tipranks.com

Zentek secures Canadian government HVAC filter standing offer

August 24, 2026 | filtsep.comF

Zentek Awarded Canadian Government Standing Offer Contract For HVAC Filters

August 20, 2026 | finance.yahoo.com

Zentek Wins Ottawa HVAC Filter Deal as ZenGUARD Gains Federal Traction

August 20, 2026 | tipranks.com

Zentek lines-up US patent for EMI shielding technology

August 19, 2026 | canadianminingjournal.comC

Hearst-area graphite deposit shows 30+ years of mining life

August 18, 2026 | timminstoday.comT

Zentek Updates Investors with June 2026 Interim Financials in New SEC Filing

August 14, 2026 | tipranks.com

New economic study due out this summer for Hearst-area graphite deposit

July 22, 2026 | northernontariobusiness.comN

Zentek Hires IMPAQ Capital to Boost North American Investor Reach

July 20, 2026 | tipranks.com

Quality Filters places first commercial order for Zentek’s ZenGuard air filtration media

July 8, 2026 | filtsep.comF

Former NHLer Jeremy Roenick becomes a player for Hearst graphite mine developer

June 27, 2026 | elliotlaketoday.comE

Zentek Creates U.S. Joint Venture to Advance Albany Ultra-High-Purity Graphite in National-Security Supply Chain

June 26, 2026 | tipranks.com

Media Sentiment Over Time

Top Headlines

View All

ZEN, PHAR, SAVE, and AXL Company Descriptions

InPlay Oil TSE:AXL

Arrow Exploration Corp. (operating in Colombia via a branches of its 100% owned subsidiary Arrow Exploration Switzerland GmbH) is a publicly traded company with a portfolio of premier Colombian oil assets that are underexploited, under-explored and offer high potential growth. The Company's business plan is to expand oil production from some of Colombia's most active basins, including the Llanos, Middle Magdalena Valley (MMV) and Putumayo Basin. The asset base is predominantly operated with high working interests, and the Brent-linked light oil pricing exposure combines with low royalties to yield attractive potential operating margins. Pursuant to certain private agreements entered between Arrow and its partner, Arrow is entitled to receive 50% of the production from the Tapir block and has the right to request approval to Ecopetrol S.A. for the assignment of 50% of all rights, interests and obligations under the Tapir Association Contract.

Pharming Group NASDAQ:PHAR

$10.46 +0.02 (+0.19%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$10.51 +0.05 (+0.44%)

As of 09/25/2026 07:46 PM Eastern

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Zentek CVE:ZEN

C$0.74 -0.01 (-1.33%)

As of 09/25/2026 03:57 PM Eastern

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZEN, PHAR, SAVE, and AXL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZEN, PHAR, SAVE, and AXL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZEN, PHAR, SAVE, and AXL Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

ZEN, PHAR, SAVE, and AXL Company Descriptions

InPlay Oil TSE:AXL

Pharming Group NASDAQ:PHAR

Zentek CVE:ZEN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZEN, PHAR, SAVE, and AXL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZEN, PHAR, SAVE, and AXL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZEN, PHAR, SAVE, and AXL Headlines

Recent News About These Companies

Media Sentiment Over Time

Top Headlines

ZEN, PHAR, SAVE, and AXL Company Descriptions

InPlay Oil TSE:AXL

Pharming Group NASDAQ:PHAR

Zentek CVE:ZEN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools